-
Most Popular
Search Results
240 results for dgse
Deep Diving the Complex Narrative Behind Novavax
With new competition joining the fray in the Covid-19 vaccine race, NVAX stock looks vulnerable. However, the enormous complexity of this arena gives Novavax a…
The Dip In Novavax Is The Perfect Buying Opportunity
With strong liquidity and a massive vaccine market, Novavax is perfectly positioned in the industry. NVAX stock is a good buy in the dip.
Novavax Stock Should Take Off as Its Successful Covid-19 Vaccine Spreads
Novavax should take off as its successful Covid-19 vaccine spreads. NVAX stock is worth at least 50% more, given a mixture of analysts’ estimates and…
Sell Ocugen Stock Now Before It Sinks Even Further
Biden’s decision to buy 100 million more of Johnson & Johnson’s vaccine, along with the potential of herd immunity, makes OCGN stock a sell.
Will This FDA Approval Affect Amgen Stock Significantly?
AMGN stock is still riding on a rocky road despite news of a new FDA approval. Here’s what Amgen investors need to know.
Inovio Pharmaceuticals Stock Isn’t Just a Solid Covid-19 Play
Encouraging preliminary results for its Covid-19 vaccine and its budding HPV solutions make INO stock a great bet at this stage.
This Mega-Scale Deal Just Gave You a Reason to Buy Novavax
In the race to bring a Covid-19 vaccine to market, Novavax just scored a major coup and that’s super-bullish for NVAX stock.
Novavax Far From Finished In the Race for a Vaccine
Four of six analysts call NVAX stock a buy. From where I sit, they’re spot on. Consider that in the first quarter of 2021, they…
Covid-19 Vaccine Makers Still Make Sense, Including Sorrento Therapeutics
SRNE stock fell out of favor as bigger vaccine developers grabbed the headlines but that may change soon.
The Upside Potential Of Novavax Is Hard To Ignore
With the Novavax share price running higher again, now might be the time for investors to ride NVAX stock to lucrative gains.
Why is Macrogenics (MGNX) Stock Down 28% Today?
Macrogenics stock is down on Wednesday after MGNX investors learned that the company is discontinuing a Phase 2 clinical trial.
Why Is Viking Therapeutics (VKTX) Stock Up 24% Today?
Viking Therapeutics stock is rising higher on Tuesday as investors in VNKTX shares react to positive Phase 1 clinical trial results.
VALN Stock Alert: 4 Things to Know About the Vaccine News Sending Valneva Soaring
Valneva is picking up attention as the biotech firm is up more than 30% today. Will its vaccine candidate power VALN stock to new highs?
Why Is Acumen Pharmaceuticals (ABOS) Stock Up 46% Today?
Acumen Pharmaceuticals (ABOS) stock is on the rise Monday after the company released data from a Phase 1 clinical trial.
Why Is Viking Therapeutics (VKTX) Stock Up 96% Today?
Viking Therapeutics stock is up on Tuesday with heavy trading of VKTX shares after the company reported positive Phase 2 trial results!
Why Is Sigilon Therapeutics (SGTX) Stock Up 691% Today?
Sigilon Therapeutics (SGTX) stock is rocketing higher on Thursday morning after Eli Lilly (LLY) agrees to acquire the company.
Aurinia Pharmaceuticals Inc Shoots Higher on Aurion Data (AUPH)
After the past week, analysts are likely tripping over themselves to upgrade Aurinia (AUPH) stock, which has nearly doubled.
PFE Stock Rises as Pfizer Requests FDA Approval of Covid-19 Treatment Paxlovid
PFE stock is up in afternoon trading as Pfizer enjoys a double round of positive news regarding its Covid-19 drugs.
OCGN Stock Alert: Why Is Ocugen Gaining Today?
Ocugen’s stock is up more than 5% after the latest clinical trial results showed its Covid-19 vaccine booster shot had positive results.
Buy Novavax In Its Post-Earnings Dip
Novavax’s Covid-19 vaccine has strong potential outside the U.S and will generate revenue. This dip is a chance to buy NVAX stock.
10 – 10 of 240 results
